ERBB2 c.52C>A ;(p.P18T)

Variant ID: 17-37856543-C-A

NM_004448.2(ERBB2):c.52C>A;(p.P18T)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Analysis of Circulating Tumor DNA to Predict Neoadjuvant Therapy Effectiveness and Breast Cancer Recurrence.

Journal Of Breast Cancer
Hao, Shuai S; Tian, Wuguo W; Zhao, Jianjie J; Chen, Yi Y; Zhang, Xiaohua X; Gao, Bo B; He, Yujun Y; Luo, Donglin D
Publication Date: 2020-08

Variant appearance in text: ERBB2: P18T
PubMed Link: 32908788
Variant Present in the following documents:
  • jbc-23-373-s004.xls, sheet 1
View BVdb publication page



CRISPR-induced RASGAP deficiencies in colorectal cancer organoids reveal that only loss of NF1 promotes resistance to EGFR inhibition.

Oncotarget
Post, Jasmin B JB; Hami, Nizar N; Mertens, Alexander E E AEE; Elfrink, Suraya S; Bos, Johannes L JL; Snippert, Hugo J G HJG
Publication Date: 2019-02-15

Variant appearance in text: HER2: P18T
PubMed Link: 30858928
Variant Present in the following documents:
  • Main text
View BVdb publication page